Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Mobile. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Mobile at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This is a phase 3 open-label, randomized, controlled, multicenter study to compare petosemtamab vs investigator's choice monotherapy in HNSCC patients for the second- and third-line treatment of incurable metastatic/recurrent disease.
Sponsor: Merus N.V.
Check if you qualify for this head and neck cancer clinical trial in Mobile, AL
If you're searching for head and neck cancer treatment options in Mobile, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mobile research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.